Banaag, Mary Cris T.
HRN: 06-24-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
AMPICILLIN 1GM (VIAL)
03/30/2023
04/06/2023
IV TT
2g
Q6
Prom X 29h
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes